海思科医药集团股份有限公司 第五届董事会第三十五次会议决议公告

Core Viewpoint - Haisco Pharmaceutical Group Co., Ltd. has convened its fifth board meeting to approve several key resolutions, including the authorization for a specific stock issuance and amendments to the company's articles of association [1][3][30]. Group 1: Stock Issuance - The board approved the proposal for the company to issue A-shares to specific investors for the year 2025, with a voting result of 5 votes in favor, 0 abstentions, and 0 against [1]. - The board is authorized to adjust the issuance price if the number of shares issued does not reach 70% of the proposed amount, ensuring the final issuance meets the required threshold [2]. Group 2: Amendments to Articles of Association - The board approved the proposal to amend the company's articles of association, with a voting result of 5 votes in favor, 0 abstentions, and 0 against [3]. - The proposed amendments include a change in the company's registered address from "No. 17, Sanxiang Avenue, Zedang Town, Shannan City, Tibet" to "No. 43, Wenxiong Avenue, Naidong District, Shannan City, Tibet" [30]. Group 3: Temporary Shareholders Meeting - The board approved the addition of temporary proposals and the cancellation of certain agenda items for the upcoming 2026 first temporary shareholders meeting, with a voting result of 5 votes in favor, 0 abstentions, and 0 against [6]. - The meeting is scheduled for January 28, 2026, with provisions for both on-site and online voting [12][13].